The Quantellect read.As of Nov 20, 2026, 4 active firms cover Novartis AG ADR: 2 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $136.00 to $170.00, so the covering firms are broadly aligned. The average target of $153.00 sits 1% above the current $151.24. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.27 next quarter toward $9.93 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Neutral
Strong Buy00%
Buy250%
Neutral250%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 20, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$153.00
+1.2% upside
Average target across 2 active firms as of Nov 20, 2026 vs $151.24 current
Highest Target$170.00
Average Target$153.00
Lowest Target$136.00
Detailed analyst forecasts for NVS
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 20, 2026, 2 of 4 active firms rate NVS a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NVS EPS & revenue forecast
EPS · NEXT QUARTER
$2.27
Range $2.21 – $2.33 · 2 analysts · +14% YoY
Next period, 2 analysts expect Novartis AG ADR to earn $2.27 a share (range $2.21 – $2.33), versus $1.99 a year earlier. Full-year consensus is $9.07, growing to $9.93 the year after.
REVENUE · NEXT QUARTER
$14.3B
Range $14.0B – $14.6B · 2 analysts · +6% YoY
Revenue is expected to reach $14.3B (range $14.0B – $14.6B), +5.8% year-over-year. Full-year consensus is $57.8B, rising to $61.7B next year.
Top analysts covering Novartis AG ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NVS.
#1
Rajesh Kumar
HSBC
Neutral
$136.00-10.1% to target
Coverage
—
+ Follow
#2
KH
Kerry Holford
Berenberg Bank
Neutral
$147.00-2.8% to target
Coverage
—
+ Follow
#3
RV
Richard Vosser
JP Morgan
Buy
No targeton NVS
Coverage
—
+ Follow
#4
JQ
James Quigley
Goldman Sachs
Sell
$118.00-22.0% to target
Coverage
—
+ Follow
#5
Jasper Hellweg
Argus Research
Buy
$170.00+12.4% to target
Coverage
—
+ Follow
NVS stock forecast FAQ
What is NVS's average 12-month price target?+
The 2 active firms with a live target average $153.00 for Novartis AG ADR over the next 12 months, ranging from a $170.00 high to a $136.00 low, as of Nov 20, 2026.
Is NVS stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 4 active firms as of Nov 20, 2026, 2 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for NVS?+
The Street-high target is $170.00 (Morgan Stanley), and the Street-low is $136.00 (HSBC). The average of all 2 active-firm targets is $153.00.
How many active Wall Street firms cover NVS?+
4 active firms have a recognized rating on Novartis AG ADR as of Nov 20, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NVS?+
Among analysts who currently cover NVS, Rajesh Kumar of HSBC has the strongest overall Quantellect track record. Their current call is Neutral with a $136.00 target.
What is Novartis AG ADR's projected EPS for next quarter?+
The consensus estimate is $2.27 per share (range $2.21 – $2.33) across 2 analysts. Full-year EPS is projected at $9.07, rising to $9.93 the following year.
How much revenue is Novartis AG ADR expected to report next quarter?+
Consensus revenue is $14.3B (range $14.0B – $14.6B). Full-year revenue is projected at $57.8B, growing to $61.7B next year.
Have analysts been upgrading or downgrading NVS lately?+
As of Nov 20, 2026, 2 of 4 active firms rate NVS a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.